TC BioPharm (Holdings) (TC BioPharm (Holdings)) Short-Term Capital Lease Obligation : $0.39 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is TC BioPharm (Holdings) Short-Term Capital Lease Obligation?

TC BioPharm (Holdings)'s Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.39 Mil.

TC BioPharm (Holdings)'s quarterly Short-Term Capital Lease Obligation increased from Jun. 2023 ($0.38 Mil) to Dec. 2023 ($0.39 Mil) and increased from Dec. 2023 ($0.39 Mil) to Mar. 2024 ($0.39 Mil).

TC BioPharm (Holdings)'s annual Short-Term Capital Lease Obligation declined from Dec. 2021 ($1.02 Mil) to Dec. 2022 ($0.40 Mil) and declined from Dec. 2022 ($0.40 Mil) to Dec. 2023 ($0.39 Mil).

TC BioPharm (Holdings) Short-Term Capital Lease Obligation Historical Data

The historical data trend for TC BioPharm (Holdings)'s Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TC BioPharm (Holdings) Short-Term Capital Lease Obligation Chart

TC BioPharm (Holdings) Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

0.54

0.60

1.02

0.40

0.39

TC BioPharm (Holdings) Quarterly Data
	Dec19	Sep20	Dec20	Jun21	Sep21	Dec21	Jun22	Dec22	Mar23	Jun23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial							0.40	-	0.38	0.39	0.39

TC BioPharm (Holdings) Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

TC BioPharm (Holdings) Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of TC BioPharm (Holdings)'s Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

TC BioPharm (Holdings) (TC BioPharm (Holdings)) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TC BioPharm (Holdings) PLC (NAS:TCBP) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

T0U:Germany

Address

Maxim 1, 2 Parklands Way, Holytown, Motherwell, Scotland, GBR, ML1 4WR

Website

https://www.tcbiopharm.com

TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform.

Executives

Renaissance Capital Partners Ltd	10 percent owner	42 SHAD THAMES, LONDON X0 SE1 2YD
Diana Elizabeth Randall	10 percent owner	C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD
Kenneth Edward Randall	10 percent owner	C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD
Mark Edward Randall	10 percent owner	C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD